NVRI heads into Thursday's earnings print with its worst weekly performance in months and a cluster of recent insider buying sitting firmly underwater.
The stock closed Tuesday at $20.14, down 7.9% on the day and 15.6% for the week. That's a sharp reversal from a recovery that had been building since late June, when short interest peaked near 3.1 million shares before retreating by roughly 22% through July. The move lower accelerated into a scheduled earnings event: NVRI reports after the close on August 13, and the price action ahead of it has been unambiguous — sellers have been in control.
The borrow market offers no obvious signal of organised short pressure. Availability is exceptionally loose, with shares-to-borrow running at more than 11 times the size of current short interest — the lending pool has plenty of room. Cost to borrow is a nominal 0.62%, up about 7% on the week but still firmly in the low-cost zone. Short positions have barely moved, edging up just 1.7% on the week to roughly 2.4 million shares after a sustained decline from early July's elevated levels. The options market is similarly calm: the put/call ratio hit its 52-week low of 0.0037 on Tuesday, the most call-skewed reading of the past year. Neither the borrow market nor the options desk is pricing in a meaningful squeeze or a directional bet against the stock.
The insider angle is harder to dismiss. In early June, the CEO, CFO, and an independent director all bought shares — the CEO's purchase alone topped $1 million at prices around $19.25–$19.43. Those buys now sit roughly at breakeven or modestly in the red at Tuesday's close. Running against them is a much larger June 1 net-sale figure: the former Chairman/President/CEO Grasberger unloaded 1.68 million shares at $15.00, accounting for the bulk of the 90-day net share movement of roughly 3.4 million shares worth $52.7 million. The June 1 sales carry a low significance score and appear to reflect a transition-related disposal rather than a directional view — Grasberger's title context suggests a departure rather than a retreat. The current leadership team buying at $19+ looks like genuine conviction, though the subsequent 15% drop is an uncomfortable short-term outcome.
The valuation picture is complicated. NVRI trades at a negative P/E — earnings are currently negative — and an EV/EBITDA of roughly 21.7x, which has drifted modestly higher on the week as the price fell faster than EBITDA estimates adjusted. Price-to-book has compressed to 0.92, just below book value. The EV/EBIT factor score ranks in the 4th percentile, indicating deep value territory on that metric — or, alternatively, that profitability remains thin. The forward EPS growth rank at the 65th percentile is the one genuinely constructive fundamental signal; analysts covering the name expect earnings improvement ahead. Neuberger Berman remains the dominant holder at 20.6% of shares, and filed a small reduction in early August — not alarming in size but notable given the timing ahead of results.
What matters next is the August 13 print itself. The stock is trading near the price at which its CEO chose to buy shares two months ago, the borrow market is relaxed, and short interest has been declining for six weeks. Whether the earnings release validates that insider conviction or confirms the recent selling pressure is the pivot point worth watching.
See the live data behind this article on ORTEX.
Open NVRI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
